Nanologica AB (DE:4YD)
FRANKFURT:4YD
Germany Market
Holding DE:4YD?
Track your performance easily

Nanologica AB (4YD) Income Statement

0 Followers

Nanologica AB Income Statement

Last quarter (Q4 2022), Nanologica AB's total revenue was kr674.00K, a decrease of -0.30% from the same quarter last year. In Q4, Nanologica AB's net income was kr-14.86M. See Nanologica AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
kr 1.55Mkr 1.55Mkr 12.91Mkr 16.14Mkr 9.23Mkr 4.15M
Cost of Revenue
kr -1.68Mkr -1.68Mkr 7.99Mkr 1.14Mkr 1.56Mkr 2.62M
Gross Profit
kr 3.24Mkr 3.23Mkr 4.92Mkr 14.99Mkr 7.66Mkr 1.53M
Operating Expense
kr 53.38Mkr 53.37Mkr 43.95Mkr 35.10Mkr 28.12Mkr 22.82M
Operating Income
kr -50.14Mkr -50.14Mkr -39.03Mkr -20.11Mkr -20.45Mkr -21.30M
Net Non Operating Interest Income Expense
kr -4.97Mkr -4.97Mkr -3.23Mkr -3.48Mkr -1.11Mkr -1.22M
Other Income Expense
------
Pretax Income
kr -55.23Mkr -55.23Mkr -44.83Mkr -22.20Mkr -21.08Mkr -20.89M
Tax Provision
-kr 0.00kr 0.00kr 0.00kr 0.00-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr -55.23Mkr -55.23Mkr -44.83Mkr -22.20Mkr -21.08Mkr -20.89M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
kr 51.69Mkr 51.69Mkr 51.95Mkr 36.24Mkr 29.68Mkr 25.44M
Net Income From Continuing And Discontinued Operation
kr -55.23Mkr -55.23Mkr -44.83Mkr -22.20Mkr -21.08Mkr -20.89M
Normalized Income
kr -55.37Mkr -55.37Mkr -42.76Mkr -23.05Mkr -20.78Mkr -22.44M
Interest Expense
kr 5.02Mkr 5.01Mkr 3.23Mkr 3.48Mkr 1.12Mkr 1.22M
EBIT
kr -50.21Mkr -50.22Mkr -41.59Mkr -18.72Mkr -19.96Mkr -19.67M
EBITDA
kr -38.35Mkr -38.36Mkr -31.13Mkr -13.05Mkr -14.51Mkr -16.22M
Currency in SEK

Nanologica AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis